Working Teams and Committees

Working Team and Committee Reports

In addition to developing the Rome Criteria for diagnosing Functional GI Disorders (FGIDs), the Rome Foundation appoints working teams that address other complex issues in the field. In choosing team members, the Board has selected senior-level members internationally who are directly involved in and who have published in the topic areas chosen by the Board. The purpose of these working team committees is to develop a summary of the research and literature to date and then offer guidelines or recommendations to help advance future research. The teams would then develop a manuscript to be published in a peer-reviewed journal.

Kok Ann Gwee MD, PhD, Chair

William E. Whitehead, PhD, Co-Chair

William D. Chey, MD, Co-Chair
Ann Arbor, Michigan, USA

Jan Tack, MD, PhD, Co-Chair
Leuven, Belgium

Dan L. Dumitrascu, MD, Chair

Magnus Simrén, MD, PhD, Chair
Gothenburg, Sweden

Giovanni Barbara, MD, Co-Chair
Bologna, Italy

Ami Sperber, MD, MSPH, Chair
Beer-Sheva, Israel

Pali Hungin, MD
United Kingdom

Emeran A. Mayer, MD, Chair
David Geffen School of Medicine at UCLA
Center for Neurovisceral Sciences & Women's Health
UCLA, Los Angeles, CA, USA

Qasim Aziz, PhD, FRCP (London), Co-Chair
The Wingate Institute
London, UK

Michael Camilleri, MD, Chair
Mayo Medical Center
Rochester, MN, USA

Douglas A. Drossman, MD, Chair
UNC Center for Functional GI & Motility Disorders
Chapel Hill, NC, USA

Lin Chang, MD, Co-Chair
UCLA CNS: Center for Neurovisceral Sciences & Women's Health
Los Angeles, CA, USA

Rome III: The Functional Gastrointestinal Disorders is the third edition of development of the "Rome criteria" for functional gastrointestinal disorders. Through the work of the editors, 87 authors from 18 countries on 14 committees, and our administrative staff, Rome III provides the culmination of a 4-year process with updates in the criteria with 17 chapters that address the organ-based criteria, basic science, physiology, pharmacology & pharmacokinetics, psychosocial aspects, gender, age, society, culture, and the patient's perspective, design of treatment trials, and development and validation of the Rome III diagnostic questionnaire. This is a list of the members whose knowledge, experience, and hard work led to this final product.

For more information on the Rome Foundation Working Teams and Committees, please contact:

Rome Foundation, Inc.
P.O. Box 6524
Raleigh, NC 27628
Phone: 919-537-9461
Fax: 919-900-7646